ASBP · Aspire Biopharma Holdings, Inc.
$8.87
-0.38 (-4.11%)
At close · Sep 4
View the 10-Q filed Aug 13, 2026
Customer concentration
— top customer 15% of revenue
One customer — 15% of revenue (the six months ended June 30, 2026)
“One customer accounted for approximately 15% of the Company’s total revenues during the six months ended June 30, 2026.”
Market Cap
$12.44M
Shares
1.40M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.